Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Talis Biomedical Corporation TLIS

Full chart Compare
Set alert

Price alert · TLIS

All alert types
2.84 USD 0.00 (+0.00%)

Apr 1, 2026, 9:30 AM EDT

1.60 Day range 2.84

52-week range unavailable

YTD
0.00%
1 year
+71.08%

Financial health

Altman Z-Score

-12.27 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.2×
FY 2018: -2.9×FY 2019: -2.3×FY 2020: -1.3×FY 2021: -0.5×FY 2022: -0.1×FY 2023: -0.2×
FY 2018 5y median -0.5× FY 2023
P/S 32.9×
FY 2018: 26.2×FY 2019: 15.7×FY 2020: 11.1×FY 2021: 11.1×FY 2022: 3.3×FY 2023: 32.9×
FY 2018 5y median 11.1× FY 2023
P/B 0.2×
FY 2018: -1.2×FY 2019: -3.0×FY 2020: -1.1×FY 2021: 0.4×FY 2022: 0.1×FY 2023: 0.2×
FY 2018 5y median 0.1× FY 2023
P/FCF -0.3×
FY 2018: -2.9×FY 2019: -2.5×FY 2020: -1.3×FY 2021: -0.5×FY 2022: -0.1×FY 2023: -0.3×
FY 2018 5y median -0.5× FY 2023
EV/EBITDA 0.7×
FY 2018: -2.7×FY 2019: -1.6×FY 2020: 0.2×FY 2021: 0.7×FY 2022: 0.8×FY 2023: 0.7×
FY 2018 5y median 0.7× FY 2023
EV/Sales -106×
FY 2018: 23.4×FY 2019: 10.3×FY 2020: -1.5×FY 2021: -15.6×FY 2022: -23.2×FY 2023: -106×
FY 2018 5y median -15.6× FY 2023
FCF Yield -396.8%
FY 2018: -34.2%FY 2019: -39.8%FY 2020: -78.7%FY 2021: -191.8%FY 2022: -856.6%FY 2023: -396.8%
FY 2018 5y median -191.8% FY 2023

Profitability

Gross Margin 90.0%
FY 2018: 100.0%FY 2019: 100.0%FY 2020: 87.4%FY 2021: -32.0%FY 2022: -129.8%FY 2023: 90.0%
FY 2018 5y median 87.4% FY 2023
Operating Margin -16217.2%
FY 2018: -896.7%FY 2019: -671.3%FY 2020: -833.6%FY 2021: -2441.2%FY 2022: -3086.1%FY 2023: -16217.2%
FY 2018 5y median -2441.2% FY 2023
Net Margin -15050.2%
FY 2018: -892.8%FY 2019: -689.8%FY 2020: -832.7%FY 2021: -2324.6%FY 2022: -3094.5%FY 2023: -15050.2%
FY 2018 5y median -2324.6% FY 2023
ROE -89.7%
FY 2018: 41.0%FY 2019: 129.8%FY 2020: 83.9%FY 2021: -81.4%FY 2022: -89.2%FY 2023: -89.7%
FY 2018 5y median -81.4% FY 2023
ROIC -72.3%
FY 2018: -267.5%FY 2019: -122.9%FY 2020: -49.8%FY 2021: -80.0%FY 2022: -70.3%FY 2023: -72.3%
FY 2018 5y median -72.3% FY 2023
ROA -65.5%
FY 2018: -187.5%FY 2019: -106.6%FY 2020: -45.9%FY 2021: -71.6%FY 2022: -66.8%FY 2023: -65.5%
FY 2018 5y median -66.8% FY 2023

Growth (YoY)

Revenue -88.7%
FY 2018: 0.0%FY 2019: 66.4%FY 2020: 175.0%FY 2021: -25.1%FY 2022: -55.4%FY 2023: -88.7%
FY 2018 FY 2023
Operating Income 40.7%
FY 2018: 0.0%FY 2019: -24.6%FY 2020: -241.5%FY 2021: -119.3%FY 2022: 43.6%FY 2023: 40.7%
FY 2018 FY 2023
EPS (diluted) 46.4%
FY 2018: 0.0%FY 2019: -28.9%FY 2020: -71.7%FY 2021: 59.8%FY 2022: 49.5%FY 2023: 46.4%
FY 2018 FY 2023
Free Cash Flow 47.2%
FY 2018: 0.0%FY 2019: -16.0%FY 2020: -282.4%FY 2021: -83.0%FY 2022: 41.6%FY 2023: 47.2%
FY 2018 FY 2023

Financial Health

Current Ratio 8.9×
FY 2018: 2.8×FY 2019: 6.0×FY 2020: 11.8×FY 2021: 12.4×FY 2022: 10.5×FY 2023: 8.9×
FY 2018 5y median 10.5× FY 2023
Quick Ratio 8.9×
FY 2018: 2.8×FY 2019: 6.0×FY 2020: 11.8×FY 2021: 12.4×FY 2022: 10.5×FY 2023: 8.9×
FY 2018 5y median 10.5× FY 2023
Debt / Equity 0.3×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: -0.0×FY 2021: 0.1×FY 2022: 0.3×FY 2023: 0.3×
FY 2018 5y median 0.1× FY 2023
Net Debt / EBITDA 0.9×
FY 2018: 0.3×FY 2019: 0.8×FY 2020: 1.5×FY 2021: 1.1×FY 2022: 0.9×FY 2023: 0.9×
FY 2018 5y median 0.9× FY 2023
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2018 5y median 0.0× FY 2023

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31